Latest Insider Transactions at Lyra Therapeutics, Inc. (LYRA)
This section provides a real-time view of insider transactions for Lyra Therapeutics, Inc. (LYRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lyra Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lyra Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2024
|
Jason Cavalier Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Oct 16
2024
|
Maria Palasis President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Mar 18
2024
|
Harlan Waksal Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
275,000
+33.87%
|
-
|
|
Nov 10
2023
|
Harlan Waksal Executive Chair |
BUY
Open market or private purchase
|
Direct |
25,000
+8.71%
|
$50,000
$2.96 P/Share
|
|
May 31
2023
|
Nbvm Gp, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,805,416
+20.88%
|
$3,610,832
$2.43 P/Share
|
|
May 31
2023
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,610,832
+23.94%
|
$7,221,664
$2.49 P/Share
|
|
May 31
2023
|
Edward T Anderson |
BUY
Open market or private purchase
|
Indirect |
1,805,416
+20.88%
|
$3,610,832
$2.43 P/Share
|
|
Jan 31
2023
|
Robert E. Richard SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Jan 31
2023
|
Corinne Noyes Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,667
+50.0%
|
-
|
|
Jun 10
2022
|
C Ann Merrifield |
BUY
Open market or private purchase
|
Direct |
4,000
+26.1%
|
$20,000
$5.05 P/Share
|
|
May 16
2022
|
C Ann Merrifield |
BUY
Open market or private purchase
|
Direct |
328
+4.28%
|
$1,640
$5.0 P/Share
|
|
May 13
2022
|
C Ann Merrifield |
BUY
Open market or private purchase
|
Direct |
3,500
+33.33%
|
$14,000
$4.81 P/Share
|
|
Apr 12
2022
|
Edward T Anderson |
BUY
Open market or private purchase
|
Direct |
118,483
+50.0%
|
$473,932
$4.22 P/Share
|
|
Apr 12
2022
|
Edward T Anderson |
BUY
Open market or private purchase
|
Indirect |
2,369,667
+36.72%
|
$9,478,668
$4.22 P/Share
|
|
Apr 12
2022
|
Nbvm Gp, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,369,667
+36.72%
|
$9,478,668
$4.22 P/Share
|
|
Apr 12
2022
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
5,924,170
+42.98%
|
$23,696,680
$4.22 P/Share
|
|
Apr 12
2022
|
Harlan Waksal Executive Chair |
BUY
Open market or private purchase
|
Direct |
236,966
+50.0%
|
$947,864
$4.22 P/Share
|
|
Jun 17
2021
|
C Ann Merrifield |
BUY
Open market or private purchase
|
Direct |
3,500
+50.0%
|
$28,000
$8.97 P/Share
|
|
Dec 16
2020
|
Nancy Lynn Md Snyderman |
BUY
Open market or private purchase
|
Direct |
1,025
+50.0%
|
$9,225
$9.72 P/Share
|
|
May 05
2020
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
625,000
+24.42%
|
$10,000,000
$16.0 P/Share
|
|
May 05
2020
|
Perceptive Advisors LLC Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
259,346
-8.97%
|
$4,149,536
$16.0 P/Share
|
|
May 05
2020
|
Perceptive Advisors LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
480,825
+14.0%
|
$3,846,600
$8.63 P/Share
|
|
May 05
2020
|
Perceptive Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,376,082
+42.48%
|
-
|